-
Raltegravir, sold
under the
brand name Isentress, is an
antiretroviral medication used,
together with
other medication, to
treat HIV/AIDS. It may also...
- Lamivudine/
raltegravir, sold
under the
brand name Dutrebis, is a fixed-dose
combination antiretroviral medication used in the
treatment of HIV/AIDS. It...
- for
raltegravir (brand name Isentress).
Research published at the time
supported the
conclusion that "[for
people living with HIV,]
raltegravir plus...
- of
drugs used in the
treatment of HIV. The
first integrase inhibitor,
raltegravir, was
approved in 2007 and
other drugs were in
clinical trials in 2011...
-
Zanamivir J05AH02
Oseltamivir J05AH03
Peramivir J05AH04
Laninamivir J05AJ01
Raltegravir J05AJ02
Elvitegravir J05AJ03
Dolutegravir J05AJ04
Cabotegravir J05AP01...
- 2020 revenue.
Other major products by the
company include Isentress (
raltegravir), an
antiretroviral medication used to
treat HIV/AIDS that had $857 million...
-
United States consists of
three medications—tenofovir,
emtricitabine and
raltegravir—as this may
reduce the risk further. PEP
treatment is
recommended after...
- all
known and
appear in a
variety of
pharmaceutical drugs including raltegravir, butalamine, fasiplon, oxolamine, and pleconaril. The 1,2,3-isomer is...
-
Indinavir Lamivudine (3TC)
Lopinavir Maraviroc Nelfinavir Nevirapine Raltegravir Ritonavir Saquinavir Tenofovir Tipranavir Zalcitabine (ddC) Zidovudine...
- inhibitor,
raltegravir, in that "MK-2048 has a
dissociation half-life of 32
hours on wild-type integrase—more than four
times that of
raltegravir", and its...
